Clinical Trial Update: A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety, tolerability, and efficacy of Tropifexor (LJN452) in patients with Primary Biliary Cholangitis has completed with results poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Tropifexor

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Primary Biliary Cholangitis | Phase 2 | Status: COMPLETED | Results posted: 2019-11-13